Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients. [electronic resource]
Producer: 20150921Description: 1596-602 p. digitalISSN:- 1879-0852
- Aged
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- blood
- Carcinoma, Squamous Cell -- blood
- Caspases -- blood
- Disease-Free Survival
- Enzyme-Linked Immunosorbent Assay
- Female
- Head and Neck Neoplasms -- blood
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Protein Kinase Inhibitors -- therapeutic use
- Sirolimus -- analogs & derivatives
- Squamous Cell Carcinoma of Head and Neck
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.